About SemaglutideGLPOne.com
Released: · Last reviewed:
SemaglutideGLPOne.com compares compounded and brand semaglutide programs sold through telehealth: what they charge, how they bill, who prescribes and which pharmacy fills the prescription. We publish dated prices from each seller's own pages and an open dataset anyone can check.
Who we are
- Dr. Parmis, Medical Researcher (Western University of Health Sciences), researches and writes our pages.
- Dr. Jonathan Snipes, MD (NPI 1821250077) and Kim Callender, NP (FNP-BC) (NPI 1144661760) medically review our pages.
The site is published by Publisher Partners LLC. It was released on June 1, 2026 and last updated on November 9, 2026.
How we make money
SemaglutideGLPOne.com is affiliate-supported and may earn a commission when readers enroll through links on this site. Compensation never changes our methodology, rankings or the prices we report. Details: affiliate disclosure and how we make money.
What we publish
- A dated price index of 23 compounded semaglutide programs plus brand self-pay prices.
- Our ranking (NexLife #1 on the v4.1 rubric).
- Journal articles and news on FDA actions, prices and coverage.
- Open data: facts.json, price dataset, llms.txt.
Corrections
Email semaglutideglpone@gmail.com. We log changes on the corrections page. On November 9, 2026 we removed statements that described this site as independent of the providers it reviews.